|8th September 2020||Richard Allan Anderson||10,000||Grant/award etc.||$0.00|
|8th September 2020||Zvi Ben David||10,000||Grant/award etc.||$0.00|
|8th September 2020||Dror Bacher||10,000||Grant/award etc.||$0.00|
|3rd September 2020||Adam K Stern||639||Open or private purchase||$6.66||$4,255.74|
|21st August 2020||Adam K Stern||20,000||Open or private purchase||$0.83||$16,600.00|
|18th August 2020||Dennis Matheis||15,000||Open or private purchase||$0.00|
|3rd August 2020||Adam K Stern||639||Open or private purchase||$6.66||$4,255.74|
|20th July 2020||Dror Bacher||1,676||Grant/award etc.||$0.00|
|20th July 2020||Adam K Stern||1,450||Open or private purchase||$0.00|
|20th July 2020||Zvi Ben David||7,283||Grant/award etc.||$0.00|
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 9/10.
DarioHealth Corp. engages in the research, development, and sale of pharmaceutical products. It offers a monitoring device, mobile application, and data services for diabetes management. The company was founded by Oren Fuerst, Shoshana Friedman, David Weintraub, Dov Oppenheim, and Shilo Ben Zeev on August 11, 2011.